BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30878553)

  • 1. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas.
    Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A
    Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting autophagy to sensitive glioma to temozolomide treatment.
    Yan Y; Xu Z; Dai S; Qian L; Sun L; Gong Z
    J Exp Clin Cancer Res; 2016 Feb; 35():23. PubMed ID: 26830677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition suppresses hormone production and cell growth in pituitary tumor cells: A potential approach to pituitary tumors.
    Satou M; Wang J; Nakano-Tateno T; Teramachi M; Aoki S; Sugimoto H; Chik C; Tateno T
    Mol Cell Endocrinol; 2024 May; 586():112196. PubMed ID: 38462123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells.
    Han H; Li J; Feng X; Zhou H; Guo S; Zhou W
    Oncotarget; 2017 Aug; 8(32):53352-53365. PubMed ID: 28881816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melding a New 3-Dimensional Agarose Colony Assay with the E(max) Model to Determine the Effects of Drug Combinations on Cancer Cells.
    Kajiwara Y; Panchabhai S; Liu DD; Kong M; Lee JJ; Levin VA
    Technol Cancer Res Treat; 2009 Apr; 8(2):163-76. PubMed ID: 19334798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of New Nanoniosome Carriers for Vorinostat: Evaluation of Anticancer Efficacy In Vitro.
    Nazari-Vanani R; Kayani Z; Karimian K; Ajdari MR; Heli H
    J Pharm Sci; 2024 May; ():. PubMed ID: 38801974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells.
    Gjika E; Pal-Ghosh S; Kirschner ME; Lin L; Sherman JH; Stepp MA; Keidar M
    Sci Rep; 2020 Oct; 10(1):16495. PubMed ID: 33020527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model.
    Chang DY; Jung JH; Kim AA; Marasini S; Lee YJ; Paek SH; Kim SS; Suh-Kim H
    Am J Cancer Res; 2020; 10(5):1429-1441. PubMed ID: 32509389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.
    Patties I; Kallendrusch S; Böhme L; Kendzia E; Oppermann H; Gaunitz F; Kortmann RD; Glasow A
    J Exp Clin Cancer Res; 2019 Oct; 38(1):420. PubMed ID: 31639020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine and alpha-lipoic acid improve antioxidant defenses and decrease oxidative stress, inflammation and serum lipid levels in ovariectomized rats via estrogen-independent mechanisms.
    Delgobo M; Agnes JP; Gonçalves RM; Dos Santos VW; Parisotto EB; Zamoner A; Zanotto-Filho A
    J Nutr Biochem; 2019 May; 67():190-200. PubMed ID: 30951973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydatid fluid from
    Chop M; Ledo C; Nicolao MC; Loos J; Cumino A; Rodriguez Rodrigues C
    Front Cell Infect Microbiol; 2024; 14():1334211. PubMed ID: 38817444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC-an important target for improving tumor radiotherapy resistance.
    Ling R; Wang J; Fang Y; Yu Y; Su Y; Sun W; Li X; Tang X
    Front Oncol; 2023; 13():1193637. PubMed ID: 37503317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy.
    Everix L; Seane EN; Ebenhan T; Goethals I; Bolcaen J
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STAT3-Regulated Autophagy Pathway in Glioblastoma.
    Laribee RN; Boucher AB; Madireddy S; Pfeffer LM
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of autophagy in regulating metabolism in the tumor microenvironment.
    Zhang P; Cheng S; Sheng X; Dai H; He K; Du Y
    Genes Dis; 2023 Mar; 10(2):447-456. PubMed ID: 37223500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
    Burko P; D'Amico G; Miltykh I; Scalia F; Conway de Macario E; Macario AJL; Giglia G; Cappello F; Caruso Bavisotto C
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Mechanism of Flavonoids on High-Grade Adult-Type Diffuse Gliomas.
    Wong SC; Kamarudin MNA; Naidu R
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells.
    Ansari MSZ; Stagni V; Iuzzolino A; Rotili D; Mai A; Del Bufalo D; Lavia P; Degrassi F; Trisciuoglio D
    Cancer Gene Ther; 2023 Jan; 30(1):124-136. PubMed ID: 36117234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future.
    Huang W; Hao Z; Mao F; Guo D
    Front Oncol; 2022; 12():911876. PubMed ID: 35785151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing autophagy regulators in brain tumors.
    Petrosyan E; Fares J; Cordero A; Rashidi A; Arrieta VA; Kanojia D; Lesniak MS
    Int J Cancer; 2022 Jul; 151(2):167-180. PubMed ID: 35179776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.